1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30,2024OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF

2、 1934For the transi?on period from to Commission File Number:001-35565AbbVie Inc.(Exact name of registrant as specified in its charter)Delaware32-0375147(State or other jurisdic?on of incorpora?on or organiza?on)(I.R.S.employer iden?fica?on number)1 North Waukegan RoadNorth Chicago,Illinois 60064-64

3、00Telephone:(847)932-7900Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Sec?on 13 or 15(d)of the Securi?es Exchange Act of 1934 during thepreceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has bee

4、n subject to such filing requirements for the past 90days.Yes No Indicate by check mark whether the registrant has submi?ed electronically every Interac?ve Data File required to be submi?ed pursuant to Rule 405 of Regula?on S-T(232.405 of this chapter)during the preceding 12 months(or for such short

5、er period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller repor?ng company,or an emerging growthcompany.See the defini?ons of“large accelerated filer,”“acce

6、lerated filer,”“smaller repor?ng company,”and emerging growth company in Rule 12b-2 of the ExchangeAct.Large Accelerated FilerAccelerated FilerNon-Accelerated FilerSmaller repor?ng companyEmerging growth companyIf an emerging growth company,indicate by check mark if the registrant has elected not to